Skip to main content
2025 STS Annual Meeting Main banner
Back

General Thoracic

Esophageal Cancer: Current Advances and Controversies

Surveillance Versus Resection Following Induction Therapy for Esophageal Cancer

Friday, January 24, 2025
10:13am – 10:21am PT
Location: 408A

    Invited Speaker(s)

  • Biniam Kidane, MD MSc FRCSC (he/him/his)

    Associate Professor
    University of Manitoba
    Winnipeg, Manitoba, Canada

    Disclosure(s): AstraZeneca: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Advisory Board (Ongoing), Unrestricted Educational grant (Ongoing); Merck: Advisory Board (Terminated, January 1, 2023), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2023); Olympus: Consultant (Ongoing); Roche: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):
Biniam Kidane, MD MSc FRCSC: AstraZeneca: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Advisory Board (Ongoing), Unrestricted Educational grant (Ongoing); Merck: Advisory Board (Terminated, January 1, 2023), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 1, 2023); Olympus: Consultant (Ongoing); Roche: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)